Explore the complexities of developing effective topical semi-solid products—from excipient selection to manufacturing scale-up. In this CPL-hosted webinar, formulation expert Chetan Chure shares best practices for defining and managing Critical Process Parameters (CPPs) and how these variables directly influence product quality, consistency, and scalability. Gain insights into formulation planning, kettle design, rheology, and in-process testing that ensure robust, reproducible results across the lifecycle of creams, ointments, and gels.
On-Demand Webinar
Development of Topical Semi-Solid Products and Significance of Critical Process Parameters (CPP) Studies
Key Learning Objectives
- Systematic formulation development of topical drug products from a scalability perspective
- Understand how Critical Process Parameters can be used to develop topical products
- Learn how to avoid potential product failure during the formulation and development process using CPPs
Speaker
Chetan Chure
Manager, Formulation Development, CPL
Chetan Chure is Manager, Formulation Development at Contract Pharmaceuticals Limited (CPL) in Mississauga, Ontario. He has spent 13 years in the research and development of semi-solid (topical) dosage forms for pharmaceutical products and holds a Master’s degree in Pharmaceutical Sciences from Birla Institute of Technology & Science, India (BITS-Pilani). Before CPL, Chetan worked for Zydus Pharmaceuticals, Glenmark Pharmaceuticals, and other pharmaceutical companies. He has authored patents and published several research articles. His primary area of interest is the development and scale-up of semi-solid (topical) dosage forms. He has been extensively involved with the development and optimization of many successful ANDA products throughout his career.